Journal of Pharmaceutical and Medicinal Chemistry

Recent years have seen a significant increase in interest in innovative drug delivery systems because of their advantages over traditional medication administration methods. This work presents a novel method of drug delivery by discussing the idea of a herbal medication in transferosomes.Transferosomes are extremely pliable vesicles that have recently been presented as novel medication carriers. They have the ability to transport large molecules through intact mammalian skin. The use of lipid vesicles as a drug delivery method for skin therapy is still controversial, despite garnering more attention this year; most relevant papers emphasise the localization effect of liposomes, with the transport mechanisms mentioned in a few cases, depending on the formulation. A novel and cutting edge medication delivery technique called transferosomes has been created to get around the clarity issue and break through the skin barrier along the transcutaneous gradient. These are certain kinds of liposomes that have phosphatidylcholine water as an edge activator, or that contain it. Biocompatible and biodegradable properties are two advantages of transferosomes. It prevents the medicinal product from being broken down by metabolism.When coupled to generate transferosomes, both hydrophilic and hydrophobic compounds have a wider range of solubility. These carriers are extremely adaptable and excellent at holding a wide range of medications, regardless of their size, molecular weight, polarity, or form. Transferosomes have the ability to transport both high and low molecular weight drugs, including insulin, sex hormone, albumin, corticosteroids, and anti-cancer medicines. Many medications, including those used to treat cancer, atopic dermatitis, hypertension, anti-edema, analgesics, anti-inflammatory agents, and cutaneous leishmaniasis, exhibit activity in transferosomes.

Background: A simple, accurate, precise and reproducible Ion Chromatography simultaneous estimation method development and validation for estimation of trace level ions in purified water.

Method: A specific and sensitive isocratic IC method was developed and validated for analysis of trace level ions in purified water using thermo scientific AS23 (4×250 mm) with flow rate 1.0 ml/min and Temperature 30 °C. The isocratic mode was used for elution and the mobile phase was 30 mM KOH.

Result: The samples were analyzed using 70 µl injection volume. The developed method was validated as per ICH Q2R1 for linearity, specificity, accuracy, precision, limit of detection, limit of quantification and robustness. The linearity of the proposed method was investigated in the range of 0.1-2.0 ppm for Fluoride, Chloride, Nitrite, Bromide, Nitrate, and Sulfate (R2 = 0.9991,0.9974,0.9997,0.9982,0.9979,0.9968). The % accuracy was found to be in the range of Fluoride, Chloride, Nitrite, Bromide, Nitrate and Sulfate was found to be in range of 98.05 –99.79%, 98.17 – 101.04%, 99.62 – 101.06%, 98.96 – 102.04%, 99.80 – 101.04%, 99.59 – 102.31%. The RSD for precision and robustness was found less than 2.

Conclusion: A rapid and sensitive isocratic elution mode analytical method was developed and validated for the simultaneous analysis for Purified water. Fluoride, Chloride, Nitrite,Bromide, Nitrate and Sulfate been validated in accordance with ICH Q2 (R1) requirements.

This review provides a thorough examination of opioid analgesics, covering their chemical structure, mechanism of action, classification, pharmacokinetics, and pharmacodynamics.Beginning with an exploration of the chemical structure of morphine and its analogues, the review elucidates the structural features critical for opioid activity, highlighting the diverse chemical scaffolds that underpin this class of medications. Subsequently, the review delves into the intricate mechanisms of action through which opioids exert their analgesic effects, focusing on their interactions with the mu, delta, and kappa opioid receptors within the central and peripheral nervous systems. Furthermore, the review provides a comprehensive classification of opioid analgesics based on their chemical structure, receptor selectivity, and clinical properties, delineating between natural, semi-synthetic, and synthetic opioids, as well as agonists, partial agonists, and antagonists. In addition, the review examines the pharmacokinetic properties of opioid analgesics, encompassing absorption, distribution, metabolism, and elimination pathways, and explores how individual pharmacokinetic profiles influence clinical dosing and therapeutic outcomes. Moreover, the review delves into the dynamic pharmacodynamics of opioids, elucidating dose response relationships, onset and duration of action, and factors influencing inter-individual variability in response to opioid therapy. Finally, the review underscores the clinical implications of opioid pharmacology, emphasizing the importance of judicious prescribing practices, individualized treatment approaches, and multidisciplinary collaboration in optimizing pain management while mitigating the risks of opioid related adverse effects, tolerance, dependence, and misuse.